Lorelin 11.25 mg Depot Injection (Leuprorelin Acetate) is a long-acting hormone-modulating medicine used in the management of advanced prostate cancer, endometriosis, uterine fibroids, and other hormone-dependent conditions. Leuprorelin acetate belongs to a class of GnRH analogues that reduce the production of sex hormones like testosterone and estrogen to help slow disease progression. The 11.25 mg depot formulation is designed for once-every-three-months administration, providing sustained hormone suppression with a single injection given by a healthcare professional. Lorelin requires a doctor’s prescription and careful monitoring due to its effects on hormone levels and potential side effects.